TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ImmuNeed AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
7,914
|
13,368
|
14,801 |
| Financial expenses |
95
|
99
|
36 |
| Earnings before taxes |
-5,364
|
-6,284
|
-5,032 |
| EBITDA |
-5,053
|
-5,932
|
-4,716 |
| Total assets |
6,398
|
9,296
|
7,352 |
| Current assets |
5,629
|
8,284
|
6,143 |
| Current liabilities |
3,140
|
5,279
|
5,014 |
| Equity capital |
2,947
|
3,396
|
1,735 |
| - share capital |
184
|
186
|
136 |
| Employees (average) |
10
|
15
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.1%
|
36.5%
|
23.6% |
| Turnover per employee |
791
|
891
|
1,057 |
| Profit as a percentage of turnover |
-67.8%
|
-47.0%
|
-34.0% |
| Return on assets (ROA) |
-82.4%
|
-66.5%
|
-68.0% |
| Current ratio |
179.3%
|
156.9%
|
122.5% |
| Return on equity (ROE) |
-182.0%
|
-185.0%
|
-290.0% |
| Change turnover |
-5,011
|
-1,509
|
6,142 |
| Change turnover % |
-39%
|
-10%
|
71% |
| Chg. No. of employees |
-5
|
1
|
4 |
| Chg. No. of employees % |
-33%
|
7%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.